T. Rowe Price Associates’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $668K | Buy |
183,264
+29,894
| +19% | +$109K | ﹤0.01% | 2162 |
|
|
2025
Q1 | $295K | Buy |
153,370
+15,465
| +11% | +$29.7K | ﹤0.01% | 2475 |
|
|
2024
Q4 | $263K | Buy |
137,905
+11,257
| +9% | +$21.5K | ﹤0.01% | 2556 |
|
|
2024
Q3 | $168K | Hold |
126,648
| – | – | ﹤0.01% | 2707 |
|
|
2024
Q2 | $130K | Buy |
126,648
+66,748
| +111% | +$68.5K | ﹤0.01% | 2705 |
|
|
2024
Q1 | $110K | Hold |
59,900
| – | – | ﹤0.01% | 2761 |
|
|
2023
Q4 | $75K | Hold |
59,900
| – | – | ﹤0.01% | 2755 |
|
|
2023
Q3 | $69K | Sell |
59,900
-22,900
| -28% | -$26.4K | ﹤0.01% | 2724 |
|
|
2023
Q2 | $76K | Sell |
82,800
-22,700
| -22% | -$20.8K | ﹤0.01% | 2734 |
|
|
2023
Q1 | $60K | Sell |
105,500
-61,400
| -37% | -$34.9K | ﹤0.01% | 2765 |
|
|
2022
Q4 | $96K | Hold |
166,900
| – | – | ﹤0.01% | 2723 |
|
|
2022
Q3 | $54K | Buy |
166,900
+119,800
| +254% | +$38.8K | ﹤0.01% | 2823 |
|
|
2022
Q2 | $17K | Sell |
47,100
-15,507
| -25% | -$5.6K | ﹤0.01% | 2929 |
|
|
2022
Q1 | $45K | Buy |
62,607
+18,149
| +41% | +$13K | ﹤0.01% | 2923 |
|
|
2021
Q4 | $100K | Sell |
44,458
-3,100
| -7% | -$6.97K | ﹤0.01% | 2869 |
|
|
2021
Q3 | $137K | Buy |
47,558
+1,535
| +3% | +$4.42K | ﹤0.01% | 2784 |
|
|
2021
Q2 | $174K | Buy |
46,023
+3,349
| +8% | +$12.7K | ﹤0.01% | 2751 |
|
|
2021
Q1 | $144K | Sell |
42,674
-69
| -0.2% | -$233 | ﹤0.01% | 2744 |
|
|
2020
Q4 | $120K | Buy |
42,743
+6,146
| +17% | +$17.3K | ﹤0.01% | 2613 |
|
|
2020
Q3 | $92K | Buy |
36,597
+9,000
| +33% | +$22.6K | ﹤0.01% | 2509 |
|
|
2020
Q2 | $375K | Buy |
27,597
+1,205
| +5% | +$16.4K | ﹤0.01% | 2170 |
|
|
2020
Q1 | $200K | Buy |
26,392
+740
| +3% | +$5.61K | ﹤0.01% | 2315 |
|
|
2019
Q4 | $162K | Buy |
25,652
+4,578
| +22% | +$28.9K | ﹤0.01% | 2417 |
|
|
2019
Q3 | $83K | Buy |
21,074
+651
| +3% | +$2.56K | ﹤0.01% | 2457 |
|
|
2019
Q2 | $99K | Buy |
20,423
+846
| +4% | +$4.1K | ﹤0.01% | 2470 |
|
|
2019
Q1 | $160K | Buy |
19,577
+200
| +1% | +$1.64K | ﹤0.01% | 2424 |
|
|
2018
Q4 | $107K | Sell |
19,377
-3,213
| -14% | -$17.7K | ﹤0.01% | 2469 |
|
|
2018
Q3 | $199K | Buy |
22,590
+297
| +1% | +$2.62K | ﹤0.01% | 2448 |
|
|
2018
Q2 | $222K | Buy |
22,293
+107
| +0.5% | +$1.07K | ﹤0.01% | 2418 |
|
|
2018
Q1 | $211K | Buy |
+22,186
| New | +$211K | ﹤0.01% | 2385 |
|